Advertisement
Advertisement

ZVRA

ZVRA logo

Zevra Therapeutics, Inc. Common Stock

9.79
USD
Sponsored
+0.07
+0.72%
Apr 14, 16:00 UTC -4
Closed
exchange

After-Market

9.60

-0.19
-1.94%

Zevra Therapeutics, Inc. Common Stock Profile

About

Zevra Therapeutics is a rare disease company melding science, data, and patient need to create transformational therapies for diseases with limited or no treatment options. Zevra Therapeutics, formerly known as KemPharm Inc., is based in CELEBRATION, Fla.

Info & Links

CEO

Neil F. McFarlane

Headquarters

101 Federal Street
Boston, MA 02110, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

https://zevra.com

Auditor

Ernst & Young LLP

Share holders

91

Employees

61

Zevra Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

563.63M

Enterprise Value

563.15M

Enterprise Value/EBITDA(ttm)

-170.29

Price to Earnings Ratio(ttm)

9.43

Price to Sales(ttm)

5.35

Price to Book(mrq)

3.53

Price to Cash(ytd)

10.27

Profitability

Gross Margin(ttm)

84.09%

Operating Margin(ttm)

60.14%

Profit Margin(ttm)

71.04%

Return on Equity(ttm)

57.42%

Return on Invested Capital(ttm)

44.26%

Return on Assets(ttm)

26.03%

Income Statement

Revenue(ttm)

106.47M

Revenue Per Share(ttm)

1.81

Gross Profit(ttm)

89.99M

EBITDA(ttm)3

-3.31M

Net Income Available to Common(ttm)

77.59M

Diluted EPS(ttm)

1.33

Share Statistics

Beta (5Y Monthly)

0.89

52-Week Change

41.88%

S&P 500 52-Week Change

28.88%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

58.71M

Dividend Yield

0.00%

Float4

57.30M

% Held by Insiders

2.40%

% Held by Institutions

35.03%

Balance Sheet

Total Cash(mrq)

191.01M

Total Cash Per Share(mrq)

3.25

Total Debt(mrq)

61.93M

Total Debt/Equity(mrq)

40.04%

Current Ratio(mrq)

5.68%

Quick Ratio(mrq)

5.63%

Book Value Per Share(mrq)

2.72

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.03

Free Cash Flow(ytd)

-1.99M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement